Lenvatinib Capsules IP 4 Mg Price in Pakistan:-

Lenvatinib Capsules IP 4 Mg Price in Pakistan is Rs:6500/-. Lenvatinib 4mg is a prescription anticancer medicine belonging to the tyrosine kinase inhibitor group. It is used under specialist medical supervision for certain advanced cancers, including differentiated thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and some cases of advanced endometrial cancer, depending on the treatment regimen. Lenvatinib works by blocking several signaling pathways involved in tumor growth and the formation of blood vessels that supply tumors.

Key Benefits of Lenvatinib Capsules IP 4 Mg:-

May help slow tumor progression
Used for selected kidney and liver cancers
Used in certain thyroid cancer treatment plans
May be combined with other cancer medicines
Targets pathways involved in cancer cell growth
Available as an oral capsule for prescribed treatment

Lenvatinib Capsules IP 4 Mg Introduction:-

Lenvatinib Capsules IP 4 Mg contain lenvatinib, a multi-targeted tyrosine kinase inhibitor used in specific cancer treatment settings. The medicine works on several receptor tyrosine kinases involved in tumor growth and angiogenesis, including pathways associated with vascular endothelial growth factor. By interfering with these signals, lenvatinib can help restrict processes that support the growth and progression of certain tumors.

Lenvatinib may be used alone or together with other medicines depending on the type of cancer and the treatment plan. The 4mg capsule is a strength that may be used as part of an individualized dosing regimen, including situations where dose adjustments are required. The appropriate dose depends on the cancer being treated, other medicines being used, and the patient’s overall condition.

How to Use Lenvatinib Capsules IP 4 Mg:-

Lenvatinib should be taken exactly according to the oncologist’s prescription. It is generally taken orally once daily and may be taken with or without food. The capsule should be swallowed with water and should not be crushed or chewed. The prescribed dose can differ significantly according to the type of cancer and may be reduced when certain side effects or kidney or liver problems occur. If a dose is missed, follow the instructions provided by the treating doctor rather than taking an extra dose.

Ingredients / Specifications:-

The active ingredient is lenvatinib, provided as lenvatinib mesylate equivalent to 4mg of lenvatinib. Lenvatinib Capsules IP 4 Mg are oral capsules belonging to the antineoplastic protein kinase inhibitor group. Pakistani regulatory information for a 4mg lenvatinib capsule specifies lenvatinib mesylate equivalent to 4mg lenvatinib and lists storage at temperatures not exceeding 30°C, protected from sunlight and moisture. Exact inactive ingredients can vary between manufacturers, so the original pack should be checked for the specific formulation.

Precautions:-

Lenvatinib requires regular medical monitoring because it can cause important adverse effects, including high blood pressure, protein in the urine, diarrhea, fatigue, decreased appetite, weight loss, nausea, mouth sores, and changes in liver function. Serious complications can also include bleeding, blood-clotting problems, heart dysfunction, kidney problems, and gastrointestinal perforation. Blood pressure, kidney function, liver function, and other laboratory parameters may need to be monitored during treatment. Patients should tell their doctor about other medicines and any existing medical conditions before starting treatment.

Who Is It For?

Lenvatinib Capsules IP 4 Mg are intended for patients who have been prescribed lenvatinib as part of a specialist cancer-treatment plan. Depending on the clinical situation, lenvatinib can be used for certain differentiated thyroid cancers, advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and selected advanced endometrial cancers. It is not a general health supplement or a medicine for self-treatment. Because dosing and combinations vary according to the cancer type and individual patient factors, this medicine should only be used under the supervision of an oncologist or other qualified healthcare professional.